Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Comparison of the Effect of Lung-protective Ventilation on Optic Nerve Sheath Diameter in Obese and Non-obese Patients

9. November 2026 aktualisiert von: Gulay ERDOGAN KAYHAN, Eskisehir Osmangazi University

Comparison of the Effect of Recruitment Maneuver and Individualized Positive End-expiratory Pressure on Optic Nerve Sheath Diameter in Obese and Non-obese Patients Undergoing Laparoscopic Surgery

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers-employed as part of an intraoperative lung-protective ventilation strategy-and individualized positive end-expiratory pressure (PEEP) on intracranial pressure, as assessed by measuring the optic nerve sheath diameter, in both obese and non-obese patients undergoing laparoscopic surgery.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Laparoscopy is widely used due to its advantages, such as less blood loss, reduced postoperative pain, and faster recovery. However, pneumoperitoneum increases thoracoabdominal pressure, which decreases venous drainage from the brain and increases cerebral blood flow and intracranial pressure (ICP). The optic nerve sheath diameter (ONSD) measurement via ultrasound is a non-invasive and reliable method for assessing ICP.

The prevalence of obesity has increased substantially over recent decades, accompanied by a growing number of obese patients undergoing laparoscopic surgery. Obesity is associated with increased intra-abdominal pressure, which may contribute to an increase in ONSD. Furthermore, the additional rise in intra-abdominal pressure induced by pneumoperitoneum may exacerbate these effects, potentially placing obese patients at greater risk of alterations in cerebral haemodynamics during laparoscopic procedures.

Atelectasis occurs in roughly 90% of all patients undergoing general anaesthesia and can persist for weeks after operation. Intraoperative lung-protective ventilation has been recommended to reduce postoperative pulmonary complications after abdominal and/or laparoscopic surgery and also in obese patients. Decreasing compliance caused by surgical/ anaesthesia factors (i.e. pneumoperitoneum, positioning, and circuit disconnect) should be treated by appropriate interventions. Individualised PEEP and alveolar recruitment manoeuvres can prevent and reverse alveolar collapse, respectively.

However, the effects of these interventions on cerebral haemodynamics, particularly ICP as assessed indirectly by ONSD measurement, remain insufficiently understood in obese and non-obese patients undergoing laparoscopic surgery.

The gol of this prospective observational study is to evaluate the effect of recruitment maneuvers and individualized PEEP- as part of intraoperative lung-protective ventilation strategy- on intracranial pressure, as assessed by measuring the optic nerve sheath diameter (ONSD), in both obese and non-obese patients undergoing laparoscopic surgery.

Studientyp

Interventionell

Einschreibung (Geschätzt)

70

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Gulay Erdogan Kayhan, Prof. Dr.
  • Telefonnummer: 905332560011
  • E-Mail: drgulayer@yahoo.com

Studieren Sie die Kontaktsicherung

  • Name: Muhammed Alpaslan Uludag, Research Assistant, MD
  • E-Mail: muho.78@live.com

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

25 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Patients over 25 years of age
  • American Soc,ety of Anesthesiology (ASA) status I-III
  • Scheduled to undergo laparoscopic abdominal surgery
  • With an expected pneumoperitoneum duration of ≥1 hour

Exclusion Criteria:

  • Patients with ocular disease
  • Patients who have undergone cranial or ocular surgery
  • Patients with a history of laparotomy
  • Individuals with bullous lung disease
  • Patients with uncontrolled chronic obstructive lung disease
  • Patients with hemodynamic instability or decompensated heart failure
  • Patients who require conversion to an open surgical procedure for any reason

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Diagnose
  • Zuteilung: Nicht randomisiert
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Sonstiges: Group O

Obese patients with BMI ≥ 30 kg/m²

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

Sonstiges: Group N

Non-obese patients

Following intubation and desufflation, an incremental alveolar recruitment maneuver (ARM) will be performed, in which the driving pressure is kept constant while the PEEP value is increased in a stepwise manner. The ARM will be performed in pressure control mode, maintaining pressure at a steady driving pressure with increments in PEEP until a peak pressure is achieved (35-40 cmH2) with a preestablished maximum PEEP. This will be maintained long enough to reopen the alveoli (5---10 breaths), and then pressure is reduced in a stepwise manner until the ideal PEEP is achieved (this being the PEEP level that produces the best Cdyn at the lowest driving pressure for a particular tidal volume setting)

ONSD will be measured at a standard level of 3 mm behind using a lineer ultrasound transducer. The measurements will be performed by an anesthesiologist experienced in ONSD measurement. The eyes will be covered with drapes; subsequently, using an ultrasound-compatible gel, measurements of both of the patient's eyes will be taken in a transverse and a sagittal plane. The mean of these measurements will then be calculated to determine the ONSD value.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t0-after anesthesia induction and entubation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t0-after anesthesia induction and entubation)
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t1- following the recruitment maneuver and the adjustment of the individualized PEEP value)
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t2- at the 30th minute of pneumoperitoneum)
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t3 - after desufflation)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t3 - after desufflation)
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t4- following a subsequent recruitment maneuver)
Optic nerve sheath diameter (ONSD)
Zeitfenster: Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Perioperative ONSD will be measured 3 mm behind the eye globe with ultrasound

Perioperative/Periprocedural (t5- at the 30th minute in the recovery room)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
MAP
Zeitfenster: Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)

Noninvasive mean arterial pressure (mmHg)

Perioperative (Noninvasive mean arterial pressure will be recorded at the times when ONSD measurement is performed)
HR
Zeitfenster: Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)

Heart rate (beat/min)

Perioperative (Heart rate will be recorded at the times when ONSD measurement is performed)
etCO2
Zeitfenster: Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

End-tidal carbon dioxide levels (mmHg)

Perioperative (End-tidal carbon dioxide levels will be recorded at the times when ONSD measurement is performed)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Airway pressures during mechanical ventilation
Zeitfenster: Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)

Ppeak, Pplato, Driving pressure (∆P), PEEP levels (cmH20) will be recorded from the sama ventilation monitor screen

Perioperative (Ppeak, Pplato, Driving pressure (∆P), PEEP levels will be recorded at the times when ONSD measurement is performed)
Postoperative complications
Zeitfenster: PONV will be questioned at the 24th hours

Postoperative nause and vomiting (PONV)

PONV will be questioned at the 24th hours
Postoperative complications
Zeitfenster: Headache will be questioned at the 24th hours

Headache

Headache will be questioned at the 24th hours
Postoperative complications
Zeitfenster: Visual disturbance will be questioned at the 24th hours

Visual disturbance

Visual disturbance will be questioned at the 24th hours

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

1. November 2027

Studienabschluss (Geschätzt)

1. November 2027

Studienanmeldedaten

Zuerst eingereicht

3. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

9. November 2026

Zuerst gepostet (Tatsächlich)

16. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

9. November 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • E-25403353-050.04-260108454

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .